116 filings
Page 6 of 6
8-K
lu56dcelo qxizsd
1 Aug 17
CRISPR Therapeutics Appoints Dr. Tony W. Ho to Head Research & Development
12:00am
8-K
i1snkml5f2j8vv6xr
27 Jul 17
Departure of Directors or Certain Officers
12:00am
8-K
btp h11g53upei
25 Jul 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
gprllt3lqx 1jzorztd
25 Jul 17
Other Events
12:00am
8-K
6rsmrtjahe32awib069
19 Jun 17
CRISPR Therapeutics Announces Patent
12:00am
8-K
eow2f
8 Jun 17
CRISPR Therapeutics Appoints James R. Kasinger as General Counsel
12:00am
8-K
l53p brvhb
2 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
58cu9v p4fcxtapluss6
11 May 17
Results of Operations and Financial Condition
12:00am
8-K
inieny8r7jzix dha1
4 May 17
Departure of Directors or Certain Officers
12:00am
8-K
ohyzreza my
27 Apr 17
Intellia Therapeutics and CRISPR Therapeutics Announce
12:00am
8-K
r26wuol
13 Apr 17
CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appeal of CRISPR/Cas9 U.S. Patent Board Decision
12:00am
8-K
kj6n0qp859n4y4ib
31 Mar 17
CRISPR Therapeutics Announces European Patent
12:00am
8-K
o8o04s
20 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
xubdbupavkx5l 5j9
15 Feb 17
Other Events
12:00am
8-K
0l9l1q
16 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
v8szb20a
8 Nov 16
Amendments to Articles of Incorporation or Bylaws
12:00am